75 related articles for article (PubMed ID: 21542294)
21. Phe120 contributes to the regiospecificity of cytochrome P450 2D6: mutation leads to the formation of a novel dextromethorphan metabolite.
Flanagan JU; Maréchal JD; Ward R; Kemp CA; McLaughlin LA; Sutcliffe MJ; Roberts GC; Paine MJ; Wolf CR
Biochem J; 2004 Jun; 380(Pt 2):353-60. PubMed ID: 14992686
[TBL] [Abstract][Full Text] [Related]
22. Functional properties of a rainbow trout CYP3A27 expressed by recombinant baculovirus in insect cells.
Lee SJ; Buhler DR
Drug Metab Dispos; 2002 Dec; 30(12):1406-12. PubMed ID: 12433811
[TBL] [Abstract][Full Text] [Related]
23. [Improvement of baculovirus expression system and purification of IL-6 protein expressed in insect cells].
Yao N; Yao LG; Kan YC; Zhou WK; Qi YP
Sheng Wu Gong Cheng Xue Bao; 2006 Jul; 22(4):572-80. PubMed ID: 16894890
[TBL] [Abstract][Full Text] [Related]
24. Metabolism of dextrorphan by CYP2D6 in different recombinantly expressed systems and its implications for the in vitro assessment of dextromethorphan metabolism.
Van LM; Sarda S; Hargreaves JA; Rostami-Hodjegan A
J Pharm Sci; 2009 Feb; 98(2):763-71. PubMed ID: 18543297
[TBL] [Abstract][Full Text] [Related]
25. Optimization of heme precursors for the expression of human cytochrome P450 2A13 and its co-expression with oxidoreductase in baculovirus/sf9 system.
Lu HY; Qiu LL; Yang XJ; Zhang XM; Zhang Z; Wang SL
J Biochem; 2013 Jun; 153(6):555-63. PubMed ID: 23463547
[TBL] [Abstract][Full Text] [Related]
26. Expression, purification, biochemical characterization, and comparative function of human cytochrome P450 2D6.1, 2D6.2, 2D6.10, and 2D6.17 allelic isoforms.
Yu A; Kneller BM; Rettie AE; Haining RL
J Pharmacol Exp Ther; 2002 Dec; 303(3):1291-300. PubMed ID: 12438554
[TBL] [Abstract][Full Text] [Related]
27. Metabolism of dextromethorphan in human liver microsomes: a rapid HPCL assay to monitor cytochrome P450 2D6 activity.
Vielnascher E; Spatzenegger M; Mayrhofer A; Klinger P; Jäger W
Pharmazie; 1996 Aug; 51(8):586-8. PubMed ID: 8794469
[TBL] [Abstract][Full Text] [Related]
28. Induction of CYP2D6 in pregnancy.
Wadelius M; Darj E; Frenne G; Rane A
Clin Pharmacol Ther; 1997 Oct; 62(4):400-7. PubMed ID: 9357391
[TBL] [Abstract][Full Text] [Related]
29. The in vitro inhibitory potential of trade herbal products on human CYP2D6-mediated metabolism and the influence of ethanol.
Hellum BH; Nilsen OG
Basic Clin Pharmacol Toxicol; 2007 Nov; 101(5):350-8. PubMed ID: 17910620
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of debrisoquin clearance in perfused rat livers and inhibition of dextromethorphan metabolism in human liver microsomes by 4-hydroxydebrisoquin or other metabolites of debrisoquin.
Jaruratanasirikul S; Cooper AD; Blaschke TF
Drug Metab Dispos; 1992; 20(3):379-82. PubMed ID: 1355711
[TBL] [Abstract][Full Text] [Related]
31. Potent inhibition of cytochrome P-450 2D6-mediated dextromethorphan O-demethylation by terbinafine.
Abdel-Rahman SM; Marcucci K; Boge T; Gotschall RR; Kearns GL; Leeder JS
Drug Metab Dispos; 1999 Jul; 27(7):770-5. PubMed ID: 10383919
[TBL] [Abstract][Full Text] [Related]
32. [Expression of bovine interferon gamma in recombinant baculovirus and determination of its antiviral activity].
Qin LT; Wang XJ; Hu S; Liu SD; Bu ZG
Wei Sheng Wu Xue Bao; 2007 Jun; 47(3):503-7. PubMed ID: 17672314
[TBL] [Abstract][Full Text] [Related]
33. Development of a rapid and sensitive high-performance liquid chromatographic method to determine CYP2D6 phenotype in human liver microsomes.
Rege B; March C; Sarkar MA
Biomed Chromatogr; 2002 Feb; 16(1):31-40. PubMed ID: 11816009
[TBL] [Abstract][Full Text] [Related]
34. A novel incubation direct injection LC/MS/MS technique for in vitro drug metabolism screening studies involving the CYP 2D6 and the CYP 3A4 isozymes.
Bhoopathy S; Xin B; Unger SE; Karnes HT
J Pharm Biomed Anal; 2005 Apr; 37(4):739-49. PubMed ID: 15797796
[TBL] [Abstract][Full Text] [Related]
35. Incorporating in vitro information on drug metabolism into clinical trial simulations to assess the effect of CYP2D6 polymorphism on pharmacokinetics and pharmacodynamics: dextromethorphan as a model application.
Dickinson GL; Rezaee S; Proctor NJ; Lennard MS; Tucker GT; Rostami-Hodjegan A
J Clin Pharmacol; 2007 Feb; 47(2):175-86. PubMed ID: 17244768
[TBL] [Abstract][Full Text] [Related]
36. Optimizing the baculovirus expression vector system.
Hitchman RB; Locanto E; Possee RD; King LA
Methods; 2011 Sep; 55(1):52-7. PubMed ID: 21945427
[TBL] [Abstract][Full Text] [Related]
37. Polymorphism of dextromethorphan metabolism: relationships between phenotype, genotype and response to the administration of encainide in humans.
Funck-Brentano C; Thomas G; Jacqz-Aigrain E; Poirier JM; Simon T; Béréziat G; Jaillon P
J Pharmacol Exp Ther; 1992 Nov; 263(2):780-6. PubMed ID: 1432700
[TBL] [Abstract][Full Text] [Related]
38. Functional properties of CYP2D6 1 (wild-type) and CYP2D6 7 (His324Pro) expressed by recombinant baculovirus in insect cells.
Evert B; Eichelbaum M; Haubruck H; Zanger UM
Naunyn Schmiedebergs Arch Pharmacol; 1997 Mar; 355(3):309-18. PubMed ID: 9089660
[TBL] [Abstract][Full Text] [Related]
39. Human NADPH-P450 oxidoreductase modulates the level of cytochrome P450 CYP2D6 holoprotein via haem oxygenase-dependent and -independent pathways.
Ding S; Yao D; Deeni YY; Burchell B; Wolf CR; Friedberg T
Biochem J; 2001 Jun; 356(Pt 2):613-9. PubMed ID: 11368792
[TBL] [Abstract][Full Text] [Related]
40. Metabolism of linear and angular furanocoumarins by Papilio polyxenes CYP6B1 co-expressed with NADPH cytochrome P450 reductase.
Wen Z; Pan L; Berenbaum MR; Schuler MA
Insect Biochem Mol Biol; 2003 Sep; 33(9):937-47. PubMed ID: 12915185
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
